The first Japanese case of intraductal cancer of the prostate with checkpoint kinase 2 mutation

• Hiroshi Hongo,
• Takeo Kosaka,
• Kohei Nakamura,
• Shuji Mikami,
• Hiroshi Nishihara,
• Mototsugu Oya

Affiliations

Hiroshi Hongo

Department of Urology, Keio University School of Medicine, Japan

Takeo Kosaka

Corresponding author.; Department of Urology, Keio University School of Medicine, Japan

Kohei Nakamura

Genomics Unit, Keio Cancer Center, Keio University School of Medicine, Japan

Shuji Mikami

Department of Diagnostic Pathology, Keio University Hospital, Japan

Hiroshi Nishihara

Genomics Unit, Keio Cancer Center, Keio University School of Medicine, Japan

Mototsugu Oya

Department of Urology, Keio University School of Medicine, Japan